Clinical implication of HLA class I expression in breast cancer - Wikidata - awgldk - TriplyDB

Clinical implication of HLA class I expression in breast cancer

Clinical implication of HLA class I expression in breast cancer

http://www.wikidata.org/entity/Q34052449

about

Peptide intra-tumor injection for cancer immunotherapy: enhancement of tumor cell antigenicity is a novel and attractive strategy Clinical implication of human leukocyte antigen (HLA)-F expression in breast cancer Plasma membrane proteomics of human breast cancer cell lines identifies potential targets for breast cancer diagnosis and treatment.Human leukocyte antigen typing using a knowledge base coupled with a high-throughput oligonucleotide probe array analysis.Prognosis of treatment response (pathological complete response) in breast cancer.Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1 Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.The immune system and inflammation in breast cancer.Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma.Comprehensive transcriptome profiling of squamous cell carcinoma of horn in Bos indicus.Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.Antigen processing and immune regulation in the response to tumours.Immunosenescence: limitations of natural killer cell-based cancer immunotherapy.SPECTRA: An Integrated Knowledge Base for Comparing Tissue and Tumor-Specific PPI Networks in Human.Clinical implications of human leukocyte antigen class I expression in endometrial cancer.HLA-G polymorphism and breast cancer.Graph-theoretical comparison of normal and tumor networks in identifying BRCA genes.Aggressive Behavior in Silent Subtype III Pituitary Adenomas May Depend on Suppression of Local Immune Response: A Whole Transcriptome Analysis.Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer.Single nucleotide variant profiles of viable single circulating tumour cells reveal CTC behaviours in breast cancer.Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients.The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer Tumors with a more complex genome have a higher frequency of HLA class I total loss: a unifying pan-cancer hypothesis Immunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens

P2860

Q27020970-28476946-9D94-42AB-999E-00A6F1A6F700 Q28266906-28BB3A23-313C-4751-86BE-B0E94237F18E Q33910532-55E4D2DB-FE92-4133-A29A-9226B1EE372D Q34579653-6BCFA9DC-D560-4F29-9996-F124C8F552A3 Q35971135-47723C52-2E9B-40AE-A125-CAC6C267CF59 Q36252643-ACD21652-BBD9-4346-8C91-3E7F652B0D7B Q36759294-4302A361-0912-4224-A00E-B7CCB2D925DC Q37033451-804884AE-A84B-4E9B-92DC-3F8C4B55F0D2 Q37703330-7EAA2F18-C922-4D46-A4AC-BFDAAFC6ECC9 Q38482331-1D16FAE2-56E9-4C35-AABF-88E9CC9C57D6 Q38547141-DEC7ED7C-FD6C-4A15-B7F7-E9A8F5E8449D Q38818628-550EA929-1B25-44C0-AB59-4B4980608BE1 Q38928938-DA9C0A10-BED5-4C55-850F-B0A9BB2DBFCE Q40451360-D878F3BE-42B7-4E44-B19D-8FBEB68E5920 Q43147365-3CD489BC-EE1F-4780-9AEB-584E84CB740E Q45261570-319168DA-F838-4B9C-9338-C2928A584617 Q47322786-35799D22-3463-48D9-A20D-9C634EC1FBE0 Q47784194-2A497A04-C9CC-4096-A965-BEBA56478709 Q50960953-E8CD96C3-2479-4C5A-AD2B-17E00D90797F Q52724992-2C075714-BB1D-4204-84F1-90D548277526 Q55364385-6D5000BF-2012-4342-9061-3BE177510AF7 Q55405564-DBE2927B-B838-446A-8F5B-77E0BB67BD7F Q57114285-33B2A557-2690-4E40-AE35-CF92896E97B5 Q58050251-D88AACF6-E48A-4654-ADBF-C6635E49779C Q58214193-B979012E-7F84-4B88-89E7-68C288AAD99C

P2860

Clinical implication of HLA class I expression in breast cancer

http://www.wikidata.org/entity/Q34052449

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Clinical implication of HLA class I expression in breast cancer

@ast

Clinical implication of HLA class I expression in breast cancer

@en

Clinical implication of HLA class I expression in breast cancer

@nl

type

label

Clinical implication of HLA class I expression in breast cancer

@ast

Clinical implication of HLA class I expression in breast cancer

@en

Clinical implication of HLA class I expression in breast cancer

@nl

prefLabel

Clinical implication of HLA class I expression in breast cancer

@ast

Clinical implication of HLA class I expression in breast cancer

@en

Clinical implication of HLA class I expression in breast cancer

@nl

P1433

Q34052449-284086C7-5D45-420B-8427-2D1916FFDEDD

P1476

Q34052449-16402ACA-0454-4023-B5B1-CA1A169E0BB9

P2093

Q34052449-0EBE3C1C-8054-415E-982F-B00A7DB9529C

Q34052449-159A1B0F-5AA6-4FB6-8510-E983759E6E9A

Q34052449-1CC723F1-27C0-4717-AF62-9B623CD84E3F

Q34052449-24EE14E3-4D87-4C5D-B73F-4B9AF045FF1E

Q34052449-333D388E-39A2-4B9C-81D2-3819E502241C

Q34052449-50613D43-7DD6-41D9-8969-B0F94C48B5A0

Q34052449-64F908EC-6AD5-4EC5-A55F-6F53E11EACF5

Q34052449-68FA2BCC-B7F3-4A1A-9D13-6A0E35232655

Q34052449-6E3E7CA4-3333-4D11-83E6-12CD76ED4CBB

Q34052449-9F558D2B-7677-4E22-8C0F-B4C3E989E106

P2860

Q34052449-3070F294-8D31-4FEE-BA20-4EA1513F3ABE

Q34052449-34D1490E-EAEE-4BE8-ADFA-08907C4CC7B1

Q34052449-34FC6D47-B21E-453E-B234-CA56A2D2452E

Q34052449-3934237A-382B-4911-A5B8-ADC1ACFDAE2E

Q34052449-54F95AD5-8C00-4EAB-AAA2-CA8BEF68D923

Q34052449-86BD7917-C3B5-4A6F-8583-ED3F9F922587

Q34052449-8EDFA21E-85A2-47D8-AD5B-5D9ADBF934CC

Q34052449-E290BD61-14F6-4C1D-ACF3-7CDE27DB40FD

Q34052449-E82F6DBC-031F-48D3-B7AC-38964C583145

Q34052449-EC383005-C902-4135-AD63-AC8453C495D6

P2888

Q34052449-C9FC5E43-897B-4126-9E3C-7CCE4607F5F3

P304

Q34052449-EFECF923-0DA8-4614-9353-03FB83CA2067

P31

Q34052449-453ADB07-53C0-4BBA-9895-25863CC0BC8B

P356

Q34052449-42227BD4-53AD-4167-80A2-C004F256AFCA

P407

Q34052449-890D92A7-0774-4C72-932B-E3938D445D4A

P478

Q34052449-E7ECA9B0-92D4-4656-9FA1-51F6DB78099F

P577

Q34052449-EA3E4AB8-1EE3-4A7E-982C-8BA95606476B

P5875

Q34052449-56A1F77D-A1B7-4A5B-BE74-3647F82B5B73

P6179

Q34052449-1E161698-AD3D-478B-AA92-721368E095DD

P698

Q34052449-D0831CD2-5CD5-446F-AAA8-2C0ED2608222

P932

Q34052449-D32121E7-C33A-4F53-8D1F-C56678B33CBC

P356

1471-2407-11-454

P1433

P1476

Clinical implication of HLA class I expression in breast cancer

@en

P2093

Chihaya Koriyama

http://www.w3.org/2001/XMLSchema#string

Heiji Yoshinaka

http://www.w3.org/2001/XMLSchema#string

Hiroshi Okumura

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Shinchi

http://www.w3.org/2001/XMLSchema#string

Koichi Kaneko

http://www.w3.org/2001/XMLSchema#string

Munetsugu Hirata

http://www.w3.org/2001/XMLSchema#string

Shinichi Ueno

http://www.w3.org/2001/XMLSchema#string

Shoji Natsugoe

http://www.w3.org/2001/XMLSchema#string

Sumiya Ishigami

http://www.w3.org/2001/XMLSchema#string

Yawara Funasako

http://www.w3.org/2001/XMLSchema#string

P2860

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story.

Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide.

Role of altered expression of HLA class I molecules in cancer progression.

Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma.

HLA typing demands for peptide-based anti-cancer vaccine.

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

Molecular pathological approaches to human tumor immunology.

Natural history of HLA expression during tumour development.

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.

P2888

1471-2407-11-454

P304

454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-11-454

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51733963

http://www.w3.org/2001/XMLSchema#string

P6179

1000291030

http://www.w3.org/2001/XMLSchema#string

P698

22014037

http://www.w3.org/2001/XMLSchema#string

P932

3214195

http://www.w3.org/2001/XMLSchema#string